Crosetto Foundation for the Reduction of Cancer Deaths
Only Transparency and Accountability Can Save CERN: Stop Billions in Waste, Unlock Life-Saving Innovations
Only Transparency and Accountability Can Save CERN: Stop Billions in Waste, Unlock Life-Saving Innovations
DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- The Crosetto Foundation for the Reduction of Cancer Deaths, an accredited nonprofit, issues an “urgent appeal to Members of the European Parliament and national parliaments: freeze funding for CERN’s Phase 2 upgrades of the ATLAS and CMS experiments”.
A Media Snippet accompanying this announcement is available in this link.
On June 20, the CERN Council approved these plans.
The Foundation sent documentation (https://bit.ly/3TMnDNI) to 720 MEPs on June 30 showing that “CERN’s plans will squander over €12 billion of taxpayer money in the next decade”.
A previous email on June 23 (https://bit.ly/4era28b), opened by 56.2% MEPs, demonstrated how CERN inefficiency has cost €4 billion already—and more critically, it has delayed life-saving medical imaging innovations that could halve cancer deaths.
The issue is CERN’s Level-1 Trigger system, which filters valuable data from radiation. “CERN’s FPGA-Based approach consumes 650 kW yet can only perform about 66 operations on each dataset arriving every 25 nanoseconds.”
“By contrast, the 3D-Flow system invented by the Italian-American scientist Dario Crosetto delivers over 8,000 operations at just 6 kW—meeting CERN’s requirements through 2042, for a fraction of the cost.” The Foundation says taxpayers deserve to know.
The 3D-Flow invention not only advances physics research but also enables the 3D-CBS (3D Complete Body Screening), an advanced PET/CT device capable of early, cost-effective cancer detection that can save millions of lives.
The Crosetto Foundation is calling for a public comparison of CERN’s and Crosetto’s systems to ensure funding goes to scientifically sound solutions.
“Your support is vital. With your contribution, we can demand accountability, prevent further waste of taxpayer funds, and accelerate life-saving cancer.”
“Your donation is an investment in a healthier, brighter future for all, with the potential to halve cancer deaths,” the Foundation emphasizes.
How You Can Help:
- Donate: Support the Crosetto Foundation online (https://crosettofoundation.org/donate-now/) or via Zelle at donate@crosettofoundation.org
- Spread the Word: Share this information and contact your representatives in the EU, your country, and the United States to demand transparency and accountability at CERN.
The Foundation has been awarded the Gold Seal for Transparency by Guidestar for eight consecutive years.
Your contributions support its mission to defend taxpayers and cancer patients by advocating for scientific integrity, transparency, and efficient use of research funds to accelerate life-saving innovations.
Contact:
Jennifer Colburn
DeSoto, Texas, jcolburn@crosettofoundation.org
https://crosettofoundation.org/
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alvotech4.7.2025 01:02:13 CEST | Press release
Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers
RIB Software3.7.2025 21:17:25 CEST | Press release
RIB Software Recognized as a Leader for Construction Management Software by Independent Research Firm
Solvay S.A.3.7.2025 18:00:00 CEST | Press release
Participation notification by Morgan Stanley
Siili Solutions Oyj3.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 3.7.2025
Virtune AB (Publ)3.7.2025 15:29:54 CEST | Press release
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for June 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom